Global Hemoperfusion 麻豆原创 Research Report 2024

Publication ID:

PB501246762

Publication Date:

January 16, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
The global Hemoperfusion market was valued at US$ 501 million in 2023 and is anticipated to reach US$ 1626.3 million by 2030, witnessing a CAGR of 18.1% during the forecast period 2024-2030.
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.
Report Scope
The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemoperfusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoperfusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemoperfusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Hemoperfusion 麻豆原创 Overview
1.1 Product Overview and Scope of Hemoperfusion
1.2 Hemoperfusion Segment by Type
1.2.1 Global Hemoperfusion 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Hemoperfusion Segment by Application
1.3.1 Global Hemoperfusion 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hepatic Encephalopathy
1.3.3 Certain Autoimmune Diseases
1.3.4 Drug Overdose
1.3.5 Specific Intoxications
1.3.6 Others
1.4 Global Hemoperfusion 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Hemoperfusion Revenue 2019-2030
1.4.2 Global Hemoperfusion Sales 2019-2030
1.4.3 Global Hemoperfusion 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemoperfusion 麻豆原创 Competition by Manufacturers
2.1 Global Hemoperfusion Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Hemoperfusion Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Hemoperfusion Average Price by Manufacturers (2019-2024)
2.4 Global Hemoperfusion Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemoperfusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemoperfusion, Product Type & Application
2.7 Hemoperfusion 麻豆原创 Competitive Situation and Trends
2.7.1 Hemoperfusion 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemoperfusion Players 麻豆原创 Share by Revenue
2.7.3 Global Hemoperfusion 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemoperfusion Retrospective 麻豆原创 Scenario by Region
3.1 Global Hemoperfusion 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemoperfusion Global Hemoperfusion Sales by Region: 2019-2030
3.2.1 Global Hemoperfusion Sales by Region: 2019-2024
3.2.2 Global Hemoperfusion Sales by Region: 2025-2030
3.3 Global Hemoperfusion Global Hemoperfusion Revenue by Region: 2019-2030
3.3.1 Global Hemoperfusion Revenue by Region: 2019-2024
3.3.2 Global Hemoperfusion Revenue by Region: 2025-2030
3.4 North America Hemoperfusion 麻豆原创 Facts & Figures by Country
3.4.1 North America Hemoperfusion 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemoperfusion Sales by Country (2019-2030)
3.4.3 North America Hemoperfusion Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemoperfusion 麻豆原创 Facts & Figures by Country
3.5.1 Europe Hemoperfusion 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemoperfusion Sales by Country (2019-2030)
3.5.3 Europe Hemoperfusion Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemoperfusion 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Hemoperfusion 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemoperfusion Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemoperfusion Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemoperfusion 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Hemoperfusion 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemoperfusion Sales by Country (2019-2030)
3.7.3 Latin America Hemoperfusion Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemoperfusion 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Hemoperfusion 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemoperfusion Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemoperfusion Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemoperfusion Sales by Type (2019-2030)
4.1.1 Global Hemoperfusion Sales by Type (2019-2024)
4.1.2 Global Hemoperfusion Sales by Type (2025-2030)
4.1.3 Global Hemoperfusion Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Hemoperfusion Revenue by Type (2019-2030)
4.2.1 Global Hemoperfusion Revenue by Type (2019-2024)
4.2.2 Global Hemoperfusion Revenue by Type (2025-2030)
4.2.3 Global Hemoperfusion Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Hemoperfusion Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemoperfusion Sales by Application (2019-2030)
5.1.1 Global Hemoperfusion Sales by Application (2019-2024)
5.1.2 Global Hemoperfusion Sales by Application (2025-2030)
5.1.3 Global Hemoperfusion Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Hemoperfusion Revenue by Application (2019-2030)
5.2.1 Global Hemoperfusion Revenue by Application (2019-2024)
5.2.2 Global Hemoperfusion Revenue by Application (2025-2030)
5.2.3 Global Hemoperfusion Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Hemoperfusion Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jafron Biomedical
6.1.1 Jafron Biomedical Corporation Information
6.1.2 Jafron Biomedical Description and Business Overview
6.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
6.1.5 Jafron Biomedical Recent Developments/Updates
6.2 Baxter (Gambro)
6.2.1 Baxter (Gambro) Corporation Information
6.2.2 Baxter (Gambro) Description and Business Overview
6.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
6.2.5 Baxter (Gambro) Recent Developments/Updates
6.3 Asahi-Kasei
6.3.1 Asahi-Kasei Corporation Information
6.3.2 Asahi-Kasei Description and Business Overview
6.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
6.3.5 Asahi-Kasei Recent Developments/Updates
6.4 Biosun Medical
6.4.1 Biosun Medical Corporation Information
6.4.2 Biosun Medical Description and Business Overview
6.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biosun Medical Hemoperfusion Product Portfolio
6.4.5 Biosun Medical Recent Developments/Updates
6.5 Kaneka
6.5.1 Kaneka Corporation Information
6.5.2 Kaneka Description and Business Overview
6.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kaneka Hemoperfusion Product Portfolio
6.5.5 Kaneka Recent Developments/Updates
6.6 Toray Medical
6.6.1 Toray Medical Corporation Information
6.6.2 Toray Medical Description and Business Overview
6.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Toray Medical Hemoperfusion Product Portfolio
6.6.5 Toray Medical Recent Developments/Updates
6.7 Cytosorbents
6.6.1 Cytosorbents Corporation Information
6.6.2 Cytosorbents Description and Business Overview
6.6.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cytosorbents Hemoperfusion Product Portfolio
6.7.5 Cytosorbents Recent Developments/Updates
6.8 Aier
6.8.1 Aier Corporation Information
6.8.2 Aier Description and Business Overview
6.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aier Hemoperfusion Product Portfolio
6.8.5 Aier Recent Developments/Updates
6.9 Zibo Kangbei
6.9.1 Zibo Kangbei Corporation Information
6.9.2 Zibo Kangbei Description and Business Overview
6.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
6.9.5 Zibo Kangbei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemoperfusion Industry Chain Analysis
7.2 Hemoperfusion Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemoperfusion Production Mode & Process
7.4 Hemoperfusion Sales and 麻豆原创ing
7.4.1 Hemoperfusion Sales Channels
7.4.2 Hemoperfusion Distributors
7.5 Hemoperfusion Customers
8 Hemoperfusion 麻豆原创 Dynamics
8.1 Hemoperfusion Industry Trends
8.2 Hemoperfusion 麻豆原创 Drivers
8.3 Hemoperfusion 麻豆原创 Challenges
8.4 Hemoperfusion 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.